Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 179 articles:
HTML format



Single Articles


    August 2022
  1. KNERR S, Guo B, Mittendorf KF, Feigelson HS, et al
    Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.
    Cancer. 2022;128:3090-3098.
    PubMed     Abstract available



  2. Trastuzumab deruxtecan beats trastuzumab emtansine in lowered disease progression, death.
    Cancer. 2022;128:2852.
    PubMed    



  3. First person profile: Monica Morrow, MD: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center
    Cancer. 2022;128:2850-2851.
    PubMed    


  4. LEHRER S, Rheinstein PH
    Neither tamoxifen nor aromatase inhibitors increase the risk of Parkinson disease in the UK Biobank cohort.
    Cancer. 2022;128:2997-2998.
    PubMed    


  5. SOLDATO D, Havas J, Crane TE, Presti D, et al
    Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
    Cancer. 2022 Aug 1. doi: 10.1002/cncr.34401.
    PubMed     Abstract available


    July 2022
  6. BARGON CA, Young-Afat DA, Ikinci M, Braakenburg A, et al
    Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis.
    Cancer. 2022 Jul 27. doi: 10.1002/cncr.34393.
    PubMed     Abstract available


  7. MOUBADDER L, Collin LJ, Nash R, Switchenko JM, et al
    Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality.
    Cancer. 2022 Jul 22. doi: 10.1002/cncr.34391.
    PubMed     Abstract available


  8. KOELMEYER LA, Gaitatzis K, Dietrich MS, Shah CS, et al
    Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Cancer. 2022 Jul 7. doi: 10.1002/cncr.34377.
    PubMed     Abstract available


  9. HYLAND CJ, Manrique OJ, Weiss A, Broyles JM, et al
    Preventive strategies for breast cancer-related lymphedema: Working toward optimal patient selection.
    Cancer. 2022 Jul 7. doi: 10.1002/cncr.34374.
    PubMed    


  10. O'ROURKE K
    Breast cancer overdiagnosis through mammograms is lower than previous estimates.
    Cancer. 2022;128:2398-2399.
    PubMed    


  11. CASANOVA NL, LeClair AM, Xiao V, Mullikin KR, et al
    Development of a workflow process mapping protocol to inform the implementation of regional patient navigation programs in breast oncology.
    Cancer. 2022;128 Suppl 13:2649-2658.
    PubMed     Abstract available


  12. BATTAGLIA TA, Gunn CM, Bak SM, Flacks J, et al
    Patient navigation to address sociolegal barriers for patients with cancer: A comparative-effectiveness study.
    Cancer. 2022;128 Suppl 13:2623-2635.
    PubMed     Abstract available


  13. CATHCART-RAKE EJ, Sanft T, Tevaarwerk AJ
    Weight gain after breast cancer diagnosis: It's complicated....
    Cancer. 2022 Jul 1. doi: 10.1002/cncr.34343.
    PubMed    


  14. SELLA T, Zheng Y, Tan-Wasielewski Z, Rosenberg SM, et al
    Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors.
    Cancer. 2022 Jul 1. doi: 10.1002/cncr.34342.
    PubMed     Abstract available


    June 2022
  15. RAUH-HAIN JA, Zubizarreta J, Nitecki R, Melamed A, et al
    Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
    Cancer. 2022 Jun 29. doi: 10.1002/cncr.34371.
    PubMed     Abstract available


  16. WATSON NW, Wander SA, Shatzel JJ, Al-Samkari H, et al
    Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer.
    Cancer. 2022 Jun 29. doi: 10.1002/cncr.34367.
    PubMed     Abstract available


  17. SITTENFELD SMC, Zabor EC, Hamilton SN, Kuerer HM, et al
    A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer.
    Cancer. 2022 Jun 17. doi: 10.1002/cncr.34352.
    PubMed     Abstract available


  18. HREBINKO KA, Bryce CL, Downs-Canner S, Diego EJ, et al
    Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors.
    Cancer. 2022;128:2258-2268.
    PubMed     Abstract available


  19. KHOSROW-KHAVAR F, Azoulay L, Montastruc JL, Montastruc F, et al
    Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study.
    Cancer. 2022;128:2339-2347.
    PubMed     Abstract available


  20. ALTUNDAG K
    Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer.
    Cancer. 2022 Jun 7. doi: 10.1002/cncr.34340.
    PubMed    


  21. CAO L, Stabellini N, Amin AL, Montero AJ, et al
    Reply to "Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer".
    Cancer. 2022 Jun 7. doi: 10.1002/cncr.34339.
    PubMed    


  22. CARROLL JE, Olmstead R, Haque R, Irwin MR, et al
    Accelerated mononuclear cell telomere attrition in breast cancer survivors with depression history: A 2-year longitudinal cohort study.
    Cancer. 2022 Jun 7. doi: 10.1002/cncr.34329.
    PubMed     Abstract available


  23. HARBECK N, Burstein HJ, Hurvitz SA, Johnston S, et al
    A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
    Cancer. 2022;128 Suppl 11:2209-2223.
    PubMed     Abstract available


  24. O'ROURKE K
    Compression sleeves reduce lymphedema after lymph node dissection: In women who had breast cancer surgery to remove their axillary lymph nodes, the sleeves helped prevent arm swelling: In women who had breast cancer surgery to remove their axillary ly
    Cancer. 2022;128:2049-2050.
    PubMed    


  25. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed     Abstract available


  26. O'BRIEN KM, Sandler DP
    Reply to "Vitamin D and breast cancer: Stop torturing the data!"
    Cancer. 2022 Jun 1. doi: 10.1002/cncr.34274.
    PubMed    


  27. BRAILLON A
    Vitamin D and breast cancer: Stop torturing the data!
    Cancer. 2022 Jun 1. doi: 10.1002/cncr.34272.
    PubMed    


    May 2022
  28. KIM G, Pastoriza JM, Qin J, Lin J, et al
    Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials.
    Cancer. 2022 May 17. doi: 10.1002/cncr.34241.
    PubMed     Abstract available


  29. JONES VC, Kruper L, Mortimer J, Ashing KT, et al
    Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions.
    Cancer. 2022 May 17. doi: 10.1002/cncr.34243.
    PubMed    


  30. KORIC A, Chang CP, Mark B, Rowe K, et al
    Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort study.
    Cancer. 2022 May 13. doi: 10.1002/cncr.34224.
    PubMed     Abstract available


  31. ZHANG Y, Mao X, Yu X, Huang X, et al
    Bone mineral density and risk of breast cancer: A cohort study and Mendelian randomization analysis.
    Cancer. 2022 May 5. doi: 10.1002/cncr.34252.
    PubMed     Abstract available


  32. WEISER R, Polychronopoulou E, Hatch SS, Haque W, et al
    Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.
    Cancer. 2022;128:1738-1747.
    PubMed     Abstract available


  33. LAU-MIN KS, Li Y, Eads JR, Mamtani R, et al
    Association between timely targeted treatment and outcomes in patients with metastatic HER2-overexpressing gastroesophageal adenocarcinoma.
    Cancer. 2022;128:1853-1862.
    PubMed     Abstract available


    April 2022
  34. O'BRIEN KM, Harmon QE, Jackson CL, Diaz-Santana MV, et al
    Vitamin D concentrations and breast cancer incidence among Black/African American and non-Black Hispanic/Latina women.
    Cancer. 2022 Apr 25. doi: 10.1002/cncr.34198.
    PubMed     Abstract available


  35. LIGIBEL JA, Pierce LJ, Bender CM, Crane TE, et al
    Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey.
    Cancer. 2022 Apr 20. doi: 10.1002/cncr.34231.
    PubMed     Abstract available


  36. O'ROURKE K
    Virginia G. Kaklamani, MD, highlights important news from SABCS: Updates from research on therapies for the treatment of breast cancer show promise: Updates from research on therapies for the treatment of breast cancer show promise.
    Cancer. 2022;128:1557-1558.
    PubMed    


  37. ANDERSON BM, White JR
    Improving the well-being of women with ductal carcinoma in situ: A worthy goal with an unclear route to success.
    Cancer. 2022;128:1571-1573.
    PubMed    


  38. ROSENBERG SM, Gierisch JM, Revette AC, Lowenstein CL, et al
    "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.
    Cancer. 2022;128:1676-1683.
    PubMed     Abstract available


  39. MELKONIAN SC, Jim MA, Pete D, Poel A, et al
    Cancer disparities among non-Hispanic urban American Indian and Alaska Native populations in the United States, 1999-2017.
    Cancer. 2022;128:1626-1636.
    PubMed     Abstract available


  40. HAYATI Z, Montazeri V, Shivappa N, Hebert JR, et al
    The association between the inflammatory potential of diet and the risk of histopathological and molecular subtypes of breast cancer in northwestern Iran: Results from the Breast Cancer Risk and Lifestyle study.
    Cancer. 2022 Apr 7. doi: 10.1002/cncr.34183.
    PubMed     Abstract available


  41. DUVAL A, Davis CG, Khoo EL, Romanow H, et al
    Mindfulness-based stress reduction and cognitive function among breast cancer survivors: A randomized controlled trial.
    Cancer. 2022 Apr 6. doi: 10.1002/cncr.34209.
    PubMed     Abstract available


  42. CAO L, Towe CW, Shenk R, Stabellini N, et al
    A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis.
    Cancer. 2022 Apr 1. doi: 10.1002/cncr.34200.
    PubMed     Abstract available


  43. TSURUDA KM, Larsen M, Roman M, Hofvind S, et al
    Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
    Cancer. 2022;128:1373-1380.
    PubMed     Abstract available


  44. BOROSUND E, Ehlers SL, Clark MM, Andrykowski MA, et al
    Digital stress management in cancer: Testing StressProffen in a 12-month randomized controlled trial.
    Cancer. 2022;128:1503-1512.
    PubMed     Abstract available


    March 2022
  45. BYCHKOVSKY BL, Lo MT, Yussuf A, Horton C, et al
    Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
    Cancer. 2022;128:1275-1283.
    PubMed     Abstract available


  46. BERLIN NL, Abrahamse P, Momoh AO, Katz SJ, et al
    Perceived financial decline related to breast reconstruction following mastectomy in a diverse population-based cohort.
    Cancer. 2022;128:1284-1293.
    PubMed     Abstract available


  47. COHEN MG, Althouse AD, Arnold RM, Bulls HW, et al
    Hope and advance care planning in advanced cancer: Is there a relationship?
    Cancer. 2022;128:1339-1345.
    PubMed     Abstract available


  48. OWUSU C, Margevicius S, Nock NL, Austin K, et al
    A randomized controlled trial of the effect of supervised exercise on functional outcomes in older African American and non-Hispanic White breast cancer survivors: Are there racial differences in the effects of exercise on functional outcomes?
    Cancer. 2022 Mar 15. doi: 10.1002/cncr.34184.
    PubMed     Abstract available


  49. BALLINGER TJ, Jiang G, Shen F, Miller KD, et al
    Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34173.
    PubMed     Abstract available


  50. RIDGEWAY JL, Jenkins SM, Borah BJ, Suman VJ, et al
    Evaluating educational interventions to increase breast density awareness among Latinas: A randomized trial in a Federally Qualified Health Center.
    Cancer. 2022;128:1038-1047.
    PubMed     Abstract available


    February 2022
  51. OSAKO T, Matsuura M, Yotsumoto D, Takayama S, et al
    A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
    Cancer. 2022 Feb 28. doi: 10.1002/cncr.34144.
    PubMed     Abstract available


  52. POTERALA JE, Wisinski KB
    Abbreviated endocrine therapy duration for low estrogen receptor-positive breast cancer: The counter to extended endocrine therapy.
    Cancer. 2022 Feb 25. doi: 10.1002/cncr.34158.
    PubMed    


  53. CAI YW, Shao ZM, Yu KD
    De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort.
    Cancer. 2022 Feb 25. doi: 10.1002/cncr.34155.
    PubMed     Abstract available



  54. Erratum to "Trajectories of fear of cancer recurrence in young breast cancer survivors".
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34142.
    PubMed    


  55. KUMAR S, Usmanova G, Nair TS, Srivastava VK, et al
    Implementation of a large-scale breast cancer early detection program in a resource-constrained setting: real-world experiences from 2 large states in India.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34114.
    PubMed     Abstract available



  56. Erratum to "Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status".
    Cancer. 2022 Feb 2. doi: 10.1002/cncr.34077.
    PubMed    


  57. MAMTANI A, Sevilimedu V, Le T, Morrow M, et al
    Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
    Cancer. 2022;128:471-478.
    PubMed     Abstract available


    January 2022
  58. TRAMA A, Tittarelli A, Barigelletti G, Botta L, et al
    Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort.
    Cancer. 2022;128:364-372.
    PubMed     Abstract available


  59. MALLA RR, Vasudevaraju P, Vempati RK, Rakshmitha M, et al
    Regulatory T cells: Their role in triple-negative breast cancer progression and metastasis.
    Cancer. 2022 Jan 6. doi: 10.1002/cncr.34084.
    PubMed     Abstract available


  60. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available


    December 2021
  61. WONG SM, Ajjamada L, Weiss AC, Prakash I, et al
    Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Cancer. 2021 Dec 17. doi: 10.1002/cncr.34065.
    PubMed     Abstract available


  62. DE ROOIJ BH, Oerlemans S, van Deun K, Mols F, et al
    Symptom clusters in 1330 survivors of 7 cancer types from the PROFILES registry: A network analysis.
    Cancer. 2021;127:4665-4674.
    PubMed     Abstract available


  63. CALIP GS, Wade NB, Guadamuz JS, Wang X, et al
    Disparities in cardiovascular disease mortality after breast cancer treatment: Methodological considerations using real-world data.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34045.
    PubMed    


  64. CONNOR AE, Kaur M, Sheng JY, Hayes JH, et al
    Racial disparities in mortality outcomes among women diagnosed with breast cancer in Maryland: Impact of cardiovascular disease and clinical characteristics.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.33889.
    PubMed     Abstract available


  65. TESCH ME, Speers C, Diocee RM, Gondara L, et al
    Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer.
    Cancer. 2021 Dec 2. doi: 10.1002/cncr.33982.
    PubMed     Abstract available


  66. CADET T, Pinheiro A, Karamourtopoulos M, Jacobson AR, et al
    Effects by educational attainment of a mammography screening patient decision aid for women aged 75 years and older.
    Cancer. 2021;127:4455-4463.
    PubMed     Abstract available


    November 2021
  67. PHILLIPS SM, Penedo FJ, Collins LM, Solk P, et al
    Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: Results from Fit2Thrive.
    Cancer. 2021 Nov 23. doi: 10.1002/cncr.34012.
    PubMed     Abstract available


  68. JAVIER-DESLOGES J, Nelson TJ, Murphy JD, McKay RR, et al
    Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Cancer. 2021 Nov 22. doi: 10.1002/cncr.33991.
    PubMed     Abstract available


  69. YU AYL, Thomas SM, DiLalla GD, Greenup RA, et al
    Disease characteristics and mortality among Asian women with breast cancer.
    Cancer. 2021 Nov 18. doi: 10.1002/cncr.34015.
    PubMed     Abstract available


  70. HAY A
    Pricing transparency among several needs for patients with high-risk breast cancer.
    Cancer. 2021;127:4122-4123.
    PubMed    


  71. LEWIS DR, Siembida EJ, Seibel NL, Smith AW, et al
    Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016.
    Cancer. 2021;127:4277-4286.
    PubMed     Abstract available


  72. KAUR M, Joshu CE, Visvanathan K, Connor AE, et al
    Trends in breast cancer incidence rates by race/ethnicity: Patterns by stage, socioeconomic position, and geography in the United States, 1999-2017.
    Cancer. 2021 Nov 3. doi: 10.1002/cncr.34008.
    PubMed     Abstract available


  73. SEEWALDT VL, Bernstein L
    Reply to Corrections: Breast cancer screening guidelines for young women of color.
    Cancer. 2021 Nov 3. doi: 10.1002/cncr.33989.
    PubMed    


  74. GORDON PB, Berg WA
    Corrections: Breast cancer screening guidelines for young women of color.
    Cancer. 2021 Nov 3. doi: 10.1002/cncr.33988.
    PubMed    


  75. IP EH, Saldana S, Miller KD, Carlos RC, et al
    Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
    Cancer. 2021 Nov 2. doi: 10.1002/cncr.33992.
    PubMed     Abstract available


  76. DILLER ML, Master VA
    Integrative surgical oncology: A model of acute integrative oncology.
    Cancer. 2021;127:3929-3938.
    PubMed     Abstract available


    October 2021
  77. NIERENGARTEN MB
    Higher mortality risk in African American women with triple-negative breast cancer.
    Cancer. 2021;127:3712-3713.
    PubMed    


  78. WEISS MC, Hibbs JE, Buckley ME, Danese SR, et al
    A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.
    Cancer. 2021 Oct 12. doi: 10.1002/cncr.33906.
    PubMed     Abstract available


  79. MURUGAPPAN MN, King-Kallimanis BL, Mangir C, Howie L, et al
    Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancer.
    Cancer. 2021 Oct 11. doi: 10.1002/cncr.33959.
    PubMed     Abstract available


  80. JATOI I, Kunkler IH
    Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33960.
    PubMed     Abstract available


  81. SCHAPIRA L, Zheng Y, Gelber SI, Poorvu P, et al
    Trajectories of fear of cancer recurrence in young breast cancer survivors.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33921.
    PubMed     Abstract available


  82. GARCIA SF, Gray RJ, Sparano JA, Tevaarwerk AJ, et al
    Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33939.
    PubMed     Abstract available


  83. BRUNELLE CL, Ag AG
    The important role of nighttime compression in breast cancer-related lymphedema treatment.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33942.
    PubMed    


  84. MCNEELY ML, Dolgoy ND, Rafn BS, Ghosh S, et al
    Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trial.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33943.
    PubMed     Abstract available


  85. FALKSON CI
    Adjuvant tamoxifen adherence in male patients with breast cancer: An ongoing challenge.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33898.
    PubMed    


  86. OKE O, Niu J, Chavez-MacGregor M, Zhao H, et al
    Adjuvant tamoxifen adherence in men with early-stage breast cancer.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33899.
    PubMed     Abstract available


  87. BERNSTEIN-MOLHO R, Galmor L, Laitman Y, Segev S, et al
    Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population.
    Cancer. 2021;127:3599-3604.
    PubMed     Abstract available


    September 2021
  88. TAMI-MAURY IM, Liao Y, Rangel ML, Gatus LA, et al
    Active living after cancer: Adaptation and evaluation of a community-based physical activity program for minority and medically underserved breast cancer survivors.
    Cancer. 2021 Sep 23. doi: 10.1002/cncr.33904.
    PubMed     Abstract available


  89. NIERENGARTEN MB
    Trio of mammography studies demonstrate enhanced screening effectiveness: Recent research on the use of adjunctive technologies and expanded-age screening provides promising results for women with dense breasts.
    Cancer. 2021;127:3279-3280.
    PubMed    


  90. PLASCAK JJ, Rundle AG, Xu X, Mooney SJ, et al
    Associations between neighborhood disinvestment and breast cancer outcomes within a populous state registry.
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33900.
    PubMed     Abstract available



  91. Erratum to "Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis".
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33816.
    PubMed    


  92. KOTSOPOULOS J, Kim SJ, Armel S, Bordeleau L, et al
    An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
    Cancer. 2021;127:3183-3193.
    PubMed     Abstract available


    August 2021
  93. FEDEWA SA, Cotter MM, Wehling KA, Wysocki K, et al
    Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic.
    Cancer. 2021 Aug 26. doi: 10.1002/cncr.33859.
    PubMed     Abstract available


  94. HENDRICK RE, Monticciolo DL, Biggs KW, Malak SF, et al
    Age distributions of breast cancer diagnosis and mortality by race and ethnicity in US Women.
    Cancer. 2021 Aug 24. doi: 10.1002/cncr.33846.
    PubMed     Abstract available


  95. SEEWALDT VL, Bernstein L
    The perils of generalization: Rethinking breast cancer screening guidelines for young women of color.
    Cancer. 2021 Aug 24. doi: 10.1002/cncr.33840.
    PubMed    


  96. YAFFE MJ
    Looking at breast cancer through the ethnic and racial lens-one size definitely does not fit all.
    Cancer. 2021 Aug 24. doi: 10.1002/cncr.33841.
    PubMed     Abstract available


  97. HENDERSON V, Ganschow P, Wang C, Hoskins KF, et al
    Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?
    Cancer. 2021 Aug 23. doi: 10.1002/cncr.33867.
    PubMed    


  98. AOKI RF, Uong SP, Gomez SL, Alexeeff SE, et al
    Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California.
    Cancer. 2021 Aug 20. doi: 10.1002/cncr.33861.
    PubMed     Abstract available


  99. NYROP KA, O'Hare EA, Teal R, Stein K, et al
    Person-centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity.
    Cancer. 2021 Aug 10. doi: 10.1002/cncr.33843.
    PubMed     Abstract available


  100. WOLDEAMANUEL YW, Blayney DW, Jo B, Fisher SE, et al
    Headache outcomes of a sleep behavioral intervention in breast cancer survivors: Secondary analysis of a randomized clinical trial.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33844.
    PubMed     Abstract available


  101. NOWAKOWSKA MK, Lei X, Thompson MT, Shaitelman SF, et al
    Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
    Cancer. 2021 Aug 3. doi: 10.1002/cncr.33797.
    PubMed     Abstract available


  102. PRINTZ C
    Mindfulness meditation helps younger breast cancer survivors.
    Cancer. 2021;127:2607.
    PubMed    


    July 2021
  103. ROBERTS SA, Gillespie TC, Shui AM, Brunelle CL, et al
    Weight loss does not decrease risk of breast cancer-related arm lymphedema.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33819.
    PubMed     Abstract available


  104. ZHAO F, Henderson TO, Cipriano TM, Copley BL, et al
    The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort.
    Cancer. 2021 Jul 22. doi: 10.1002/cncr.33798.
    PubMed     Abstract available


  105. POTEAT TC, Adams MA, Malone J, Geffen S, et al
    Delays in breast cancer care by race and sexual orientation: Results from a national survey with diverse women in the United States.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33629.
    PubMed     Abstract available


  106. FAN Q, Yao XA, Han X
    Spatial variation and disparity in female breast cancer relative survival in the United States.
    Cancer. 2021 Jul 15. doi: 10.1002/cncr.33801.
    PubMed     Abstract available


  107. KURIAN AW, Hughes E, Simmons T, Bernhisel R, et al
    Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Cancer. 2021 Jul 6. doi: 10.1002/cncr.33767.
    PubMed     Abstract available


    June 2021
  108. GREER AC, Lanes A, Poorvu PD, Kennedy P, et al
    The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33601.
    PubMed     Abstract available


  109. BROWN JC, Sarwer DB, Troxel AB, Sturgeon K, et al
    A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33752.
    PubMed     Abstract available


  110. RENTSCHER KE, Zhao X, Small BJ, Cohen HJ, et al
    Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33687.
    PubMed     Abstract available


  111. LYNCE F, Blackburn MJ, Zhuo R, Gallagher C, et al
    Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33620.
    PubMed     Abstract available


  112. MAKHNOON S, Tran G, Levin B, Mattie KD, et al
    Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33668.
    PubMed     Abstract available


  113. PRINTZ C
    Female breast cancer most commonly diagnosed cancer globally.
    Cancer. 2021;127:1952-1953.
    PubMed    


  114. PRINTZ C
    Some patients with postmenopausal breast cancer can avoid adjuvant chemotherapy: Data indicate that some postmenopausal women with breast cancer can safely skip adjuvant chemotherapy.
    Cancer. 2021;127:1951-1952.
    PubMed    


  115. PRINTZ C
    Less-educated minority women have less 3-D mammography access.
    Cancer. 2021;127:1953.
    PubMed    


  116. WHITE DP, Kurian AW, Stevens JL, Liu B, et al
    Receipt of guideline-concordant care among young adult women with breast cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33652.
    PubMed     Abstract available


  117. MCCARTHY AM, Ehsan S, Appel S, Welch M, et al
    Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33661.
    PubMed     Abstract available


  118. HENSING WL, Poplack SP, Herman CR, Sutcliffe S, et al
    Racial differences in no-show rates for screening mammography.
    Cancer. 2021;127:1857-1863.
    PubMed     Abstract available


    May 2021
  119. DHAKAL A, Falkson C, O'Regan RM
    Adjuvant cyclin-dependent kinase 4/6 inhibition in hormone receptor-positive breast cancer: One Monarch to rule them all?
    Cancer. 2021 May 28. doi: 10.1002/cncr.33650.
    PubMed     Abstract available


  120. SUNG H, Freedman RA, Siegel RL, Hyun N, et al
    Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
    Cancer. 2021 May 18. doi: 10.1002/cncr.33602.
    PubMed     Abstract available


  121. PRINTZ C
    Immune Factors Tied to Aggressive Breast Cancers in Black Patients.
    Cancer. 2021;127:1546.
    PubMed    


  122. MATTHYS MB, Dempsey AM, Melisko ME, Dreher N, et al
    Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
    Cancer. 2021 May 6. doi: 10.1002/cncr.33496.
    PubMed     Abstract available


  123. FARVID MS, Spence ND, Rosner BA, Chen WY, et al
    Consumption of sugar-sweetened and artificially sweetened beverages and breast cancer survival.
    Cancer. 2021 May 4. doi: 10.1002/cncr.33461.
    PubMed     Abstract available


    April 2021
  124. DI MEGLIO A, Gbenou AS, Martin E, Pistilli B, et al
    Unhealthy behaviors after breast cancer: Capitalizing on a teachable moment to promote lifestyle improvements.
    Cancer. 2021 Apr 22. doi: 10.1002/cncr.33565.
    PubMed     Abstract available


  125. SELLA T, Poorvu PD, Ruddy KJ, Gelber SI, et al
    Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors.
    Cancer. 2021 Apr 22. doi: 10.1002/cncr.33596.
    PubMed     Abstract available


  126. TAYLOR CE, Meisel JL
    We have to talk about it: Bringing fertility into the conversation for young women with breast cancer.
    Cancer. 2021 Apr 22. doi: 10.1002/cncr.33595.
    PubMed    


  127. ADRADA BE, Candelaria R, Moulder S, Thompson A, et al
    Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
    Cancer. 2021 Apr 20. doi: 10.1002/cncr.33604.
    PubMed     Abstract available


  128. STANGL S, Rauch S, Rauh J, Meyer M, et al
    Disparities in accessibility to evidence-based breast cancer care facilities by rural and urban areas in Bavaria, Germany.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33493.
    PubMed     Abstract available


  129. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed     Abstract available


  130. CORSO G, Maisonneuve P, Veronesi P
    Impact of radiation and hormonal therapy on the locoregional recurrence of elderly breast cancer: Are these necessary after breast-conserving surgery?
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33550.
    PubMed    


  131. TRINGALE KR, Berger ER, Heerdt AS, Braunstein LZ, et al
    Reply to Impact of radiation and hormonal therapy on the locoregional recurrence of elderly breast cancer: Are these necessary after breast-conserving surgery?
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33551.
    PubMed    


  132. HENDERSON V, Chukwudozie IB, Comer-Hagans D, Coffey V, et al
    Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33525.
    PubMed     Abstract available


  133. SADIGH G, Gray RJ, Sparano JA, Yanez B, et al
    Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33527.
    PubMed     Abstract available


  134. CONNOR AE, Schmaltz CL, Jackson-Thompson J, Visvanathan K, et al
    Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33530.
    PubMed     Abstract available


    March 2021
  135. TAMIRISA N, Lin H, Shen Y, Shaitelman SF, et al
    Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-a National Cancer Database analysis.
    Cancer. 2021 Mar 18. doi: 10.1002/cncr.33489.
    PubMed     Abstract available


  136. FAN R, Chen Y, Nechuta S, Cai H, et al
    Prediction models for breast cancer prognosis among Asian women.
    Cancer. 2021 Mar 11. doi: 10.1002/cncr.33425.
    PubMed     Abstract available


    February 2021
  137. NYANTE SJ, Benefield TS, Kuzmiak CM, Earnhardt K, et al
    Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33460.
    PubMed     Abstract available


  138. EMERSON MA, Achacoso NS, Benefield HC, Troester MA, et al
    Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaska Native breast cancer survivors.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33423.
    PubMed     Abstract available


  139. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed     Abstract available


  140. OBENG-GYASI S, Timsina LR, Bhattacharyya O, Fisher CS, et al
    Bankruptcy among insured patients with surgical breast cancer: Who is at risk?
    Cancer. 2021 Feb 19. doi: 10.1002/cncr.33468.
    PubMed     Abstract available


  141. BOWER JE, Ganz PA, Irwin MR, Cole SW, et al
    Do all patients with cancer experience fatigue? a longitudinal study of fatigue trajectories in women with breast cancer.
    Cancer. 2021 Feb 19. doi: 10.1002/cncr.33327.
    PubMed     Abstract available


  142. PRINTZ C
    Breast cancer screening for women in their 40s reduces mortality.
    Cancer. 2021;127:497.
    PubMed    


  143. SIMON MS, Hastert TA, Barac A, Banack HR, et al
    Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
    Cancer. 2021;127:598-608.
    PubMed     Abstract available


  144. NABI J, Tully KH, Cole AP, Marchese M, et al
    Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Cancer. 2021;127:577-585.
    PubMed     Abstract available


  145. OWUSU C, Nock NL, Feuntes V, Margevicius S, et al
    IMPROVE, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and Non-Hispanic White breast cancer survivors from diverse socioeconomic backgrounds: Recruitment strategies
    Cancer. 2021 Feb 4. doi: 10.1002/cncr.33430.
    PubMed     Abstract available


  146. LEE RT, Kwon N, Wu J, To C, et al
    Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer.
    Cancer. 2021 Feb 1. doi: 10.1002/cncr.33324.
    PubMed     Abstract available


    January 2021
  147. REEDER-HAYES KE, Mayer SE, Lund JL
    Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33367.
    PubMed     Abstract available


  148. TRINGALE KR, Berger ER, Sevilimedu V, Wen HY, et al
    Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.
    Cancer. 2021 Jan 26. doi: 10.1002/cncr.33422.
    PubMed     Abstract available


  149. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    PubMed     Abstract available


  150. PRINTZ C
    Drug shows significant early promise in early, high-risk, HR-positive, HER2-negative breast cancer: Interim data indicate that adding abemaciclib to hormonal therapy reduces recurrence risk.
    Cancer. 2021;127:169-170.
    PubMed    


    December 2020
  151. KNAPP GC, Tansley G, Olasehinde O, Wuraola F, et al
    Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population-based study.
    Cancer. 2020 Dec 28. doi: 10.1002/cncr.33394.
    PubMed     Abstract available


  152. SHAO D, Zhang H, Cui N, Sun J, et al
    The efficacy and mechanisms of a guided self-help intervention based on mindfulness in patients with breast cancer: A randomized controlled trial.
    Cancer. 2020 Dec 17. doi: 10.1002/cncr.33381.
    PubMed     Abstract available


  153. PRINTZ C
    Early breast cancer screening in childhood cancer survivors treated with chest radiation may reduce deaths by more than 50.
    Cancer. 2020;126:5197.
    PubMed    


  154. SEAH DS, Leone JP, Openshaw TH, Scott SM, et al
    Perceptions of patients with early stage breast cancer toward research biopsies.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33371.
    PubMed     Abstract available


  155. LEONE JP, Cole BF, Regan MM, Thurlimann B, et al
    Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
    Cancer. 2020 Dec 8. doi: 10.1002/cncr.33318.
    PubMed     Abstract available


  156. NYROP KA, Damone EM, Deal AM, Carey LA, et al
    Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer.
    Cancer. 2020 Dec 7. doi: 10.1002/cncr.33288.
    PubMed     Abstract available


  157. TAYLOR CE, Meisel JL
    Weighing the influence of race and obesity on outcomes in patients with early-stage breast cancer.
    Cancer. 2020 Dec 7. doi: 10.1002/cncr.33290.
    PubMed    


  158. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    PubMed     Abstract available


  159. MOHL A, Orban E, Jung AY, Behrens S, et al
    Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33363.
    PubMed     Abstract available


    November 2020
  160. PARK J, Rodriguez JL, O'Brien KM, Nichols HB, et al
    Health-related quality of life outcomes among breast cancer survivors.
    Cancer. 2020 Nov 25. doi: 10.1002/cncr.33348.
    PubMed     Abstract available


  161. NYROP KA, Deal AM, Chen YT, Reeve BB, et al
    Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
    Cancer. 2020 Nov 20. doi: 10.1002/cncr.33329.
    PubMed     Abstract available


  162. BERRIAN JL, Liu Y, Lian M, Schmaltz CL, et al
    Relationship between insurance status and outcomes for patients with breast cancer in Missouri.
    Cancer. 2020 Nov 17. doi: 10.1002/cncr.33330.
    PubMed     Abstract available


  163. FAYANJU OM, Ren Y, Stashko I, Power S, et al
    Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis.
    Cancer. 2020 Nov 11. doi: 10.1002/cncr.33310.
    PubMed     Abstract available


  164. DURAND MA, Yen RW, O'Malley AJ, Schubbe D, et al
    What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.
    Cancer. 2020 Nov 10. doi: 10.1002/cncr.33248.
    PubMed     Abstract available


  165. DESANTIS CE, Siegel RL
    The importance of comprehensive data and statistical testing in the interpretation of breast cancer incidence trends.
    Cancer. 2020 Nov 10. doi: 10.1002/cncr.33263.
    PubMed    


  166. DESAI NV, Yadav S, Batalini F, Couch FJ, et al
    Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years.
    Cancer. 2020 Nov 4. doi: 10.1002/cncr.33305.
    PubMed     Abstract available


  167. CHU QD, Li T, Hsieh MC, Yi Y, et al
    Positive impact of the Patient Protection and Affordable Care Act Medicaid expansion on Louisiana women with breast cancer.
    Cancer. 2020 Nov 3. doi: 10.1002/cncr.33265.
    PubMed     Abstract available


  168. SEEWALDT VL
    Time for action: The Patient Protection and Affordable Care Act Medicaid expansion significantly improves breast cancer care for women in Louisiana.
    Cancer. 2020 Nov 3. doi: 10.1002/cncr.33264.
    PubMed    


    October 2020
  169. WILLIAMS CP, Gallagher KD, Deehr K, Aswani MS, et al
    Quantifying treatment preferences and their association with financial toxicity in women with breast cancer.
    Cancer. 2020 Oct 27. doi: 10.1002/cncr.33287.
    PubMed     Abstract available


  170. PASKETT ED, Le-Rademacher J, Oliveri JM, Liu H, et al
    A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33183.
    PubMed     Abstract available


  171. NAUGHTON MJ, Liu H, Seisler DK, Le-Rademacher J, et al
    Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33184.
    PubMed     Abstract available


  172. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    PubMed     Abstract available


    September 2020
  173. GREENE N, Malone J, Adams MA, Dean LT, et al
    "This is some mess right here": Exploring interactions between Black sexual minority women and health care providers for breast cancer screening and care.
    Cancer. 2020 Sep 29. doi: 10.1002/cncr.33219.
    PubMed     Abstract available


  174. EMERSON MA, Golightly YM, Aiello AE, Reeder-Hayes KE, et al
    Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women.
    Cancer. 2020 Sep 21. doi: 10.1002/cncr.33121.
    PubMed     Abstract available


  175. PRINTZ C
    TAILORx study finds early, abrupt cognitive decline among patients with breast cancer.
    Cancer. 2020;126:4083.
    PubMed    


    June 2020

  176. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors.
    Cancer. 2020;126:2566-2570.
    PubMed     Abstract available


    May 2020
  177. HENLEY SJ, Thomas CC, Lewis DR, Ward EM, et al
    Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.
    Cancer. 2020;126:2250-2266.
    PubMed     Abstract available


    April 2020
  178. MAHORTER SS, Knerr S, Bowles EJA, Wernli KJ, et al
    Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial.
    Cancer. 2020;126:1614-1621.
    PubMed     Abstract available


    November 2019
  179. RAMIREZ AG, Choi BY, Munoz E, Perez A, et al
    Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors.
    Cancer. 2019 Nov 19. doi: 10.1002/cncr.32626.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: